Assyro AI

Orange Book product · Generic (ANDA)

FLUDEOXYGLUCOSE F18

FLUDEOXYGLUCOSE F-18

Generic (ANDA)ANDA 203994RX NORTHLAND
View FLUDEOXYGLUCOSE F-18 familyOpen on FDA Orange Book

At a glance

Feb 04, 2015

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 04, 2015

    11 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

FLUDEOXYGLUCOSE F-18

Strength

4-500mCi/ML

Dosage form

INJECTABLE

Route

INTRAVENOUS

TE code

Not listed

Application

ANDA 203994

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of FLUDEOXYGLUCOSE F-18

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo